IL-2-producing T

Shivangi Dave, Holly Bachus, Nathan Santiago, Audrey Meloun, Margery Smelkinson, Jeremy B Foote, Thomas Hill, Christopher Fucile, Alexander F Rosenberg, André Ballesteros-Tato

Abstract read

PubMed Publisher

In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shivangi DaveThe Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Holly BachusThe Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Nathan SantiagoThe Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Audrey MelounThe Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-9433-1235

Margery SmelkinsonBiological Imaging, Research Technology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-7777-5574

Jeremy B FooteDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, AL, USA.

Thomas HillCollaborative Bioinformatics Resource, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Christopher FucileDepartment of Biomedical Informatics and Data Science, The University of Alabama at Birmingham, Birmingham, AL, USA.

Alexander F RosenbergDepartment of Biomedical Informatics and Data Science, The University of Alabama at Birmingham, Birmingham, AL, USA.

André Ballesteros-TatoThe Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. andre.ballesteros-tato@nih.gov.ORCID http://orcid.org/0000-0002-4833-593X

Funding

U.S. Department of Health & Human Services | National Institutes of Health (NIH) 1R01 AI162698

6 · The paper itself

Abstract

Follicular helper T (T

Identifiers

PMID42907581

DOI10.1016/j.csbj.2021.06.043

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.